Opposing the recent ban on stem cells, European scientists raise an uproar against the decision of European Court of Justice to disallow the use of embryonic stem cell based therapies in the European region. This came as a blow to the scientists and the Pharmaceutical sector which was diligently working on the Stem Cell based research for the treatment of various disorders. Scientists believe that such a ban can put Europe at disadvantage in the global society. If there will be no patents granted in this area then it is nearly impossible to obtain approval from the drug industries to invest in the stem cells based research. As the theory of “Commercialization and Development” says: There will be no major breakthrough inventions if there is no commercialization of such inventions.
This decision can bring a severe blow to the drug firms like AstraZeneca, Roche, Avantea, Advanced Cell Technology and Geron Corp., who have been involved in the Embryonic Stem Cell research based technologies. Although European Court of Justice decision to deny Stem Cell based patents is relying on the moral and ethical grounds but scientists have a firm opinion that this decision can lead to obstruction in the path of new medical developments. Well so far this story has unfolded, but what will be the future of stem cell based research in Europe, will be something to watch for.
(Image courtesy link )
